.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Novartis
Citi
McKesson
Federal Trade Commission
Dow
McKinsey
Argus Health
Queensland Health
Healthtrust

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for Biologics License Application 125288

« Back to Dashboard

Summary for BLA: 125288

Tradename:
NULOJIX
Applicant:
Bristol Myers Squibb
Ingredient:
belatacept
Patents:9
Approval Date:Jun 15, 2011
Suppliers: see list1
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Bristol Myers Squibb
NULOJIX
belatacept
INJECTABLE; INJECTION1252880012011-06-158,808,689 Perle Bioscience, Inc. (Atlanta, GA) Levetan; Claresa (Bryn Mawr, PA) ► SubscribeRXsearch
Bristol Myers Squibb
NULOJIX
belatacept
INJECTABLE; INJECTION1252880012011-06-158,895,010 Bristol-Myers Squibb Company (Princeton, NJ) Domantis Limited (Brentford, Middlesex, GB) Nadler; Steven G. (Princeton, NJ), Tamura; James K. (Yardley, PA), Price; Laura (Langhorne, PA), Rehfuss; Robert P. (North Wales, PA), Suchard; Suzanne J. (Wilmington, DE), Suri; Anish (Yardley, PA), Bryson; James William (Langhorne, PA), Yamniuk; Aaron (Lawrenceville, NJ), Grant; Steven (Swaffham Prior, GB), Ignatovich; Olga (Cambridge, GB), Drew; Philip (Histon, GB) ► SubscribeRXsearch
Bristol Myers Squibb
NULOJIX
belatacept
INJECTABLE; INJECTION1252880012011-06-158,956,830 Momenta Pharmaceuticals, Inc. (Cambridge, MA) Prentice; Holly (Carlisle, MA), Tijani; Rasheed (Haverhill, MA), Belongia; Brett (North Andover, MA) ► SubscribeRXsearch
Bristol Myers Squibb
NULOJIX
belatacept
INJECTABLE; INJECTION1252880012011-06-159,005,616 Amplimmune, Inc. (Gaithersburg, MD) Langermann; Solomon (Baltimore, MD), Liu; Linda (Clarksville, MD) ► SubscribeRXsearch
Bristol Myers Squibb
NULOJIX
belatacept
INJECTABLE; INJECTION1252880012011-06-159,044,459 ALS THERAPY DEVELOPMENT INSTITUTE (Cambridge, MA) Perrin; Steven (Newbury, MA), Lincecum; John Monteith (Jamaica Plain, MA), Gill; Alan (Reading, MA), Vieira; Fernando (Boston, MA) ► SubscribeRXsearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
Healthtrust
Julphar
Boehringer Ingelheim
McKesson
US Army
Mallinckrodt
Colorcon
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot